Results 241 to 250 of about 6,094,547 (359)

Alternative splicing fine-tunes prey shift of Coccinellini lady beetles to non-target insect. [PDF]

BMC Genomics
Tang X, Xia X, Liu Y, Hong X, Huang Y, Li G, Liang Y, Wang X, Pang H, Yang Y.   +9 more
europepmc   +1 more source

On the Alternative Fuel to Diesel Engine

, 1942
Rinjiro Nakamura, Yasuhisa MIYATA
openalex   +2 more sources

Beyond cytotoxic T cells: reprogrammed regulatory T cells help facilitate response to dual checkpoint blockade

Molecular Oncology, EarlyView.
Rolig, Peng, and colleagues have shed new light on how dual blockade of PD1 and LAG3 enhances antitumor immunity. They found that response to immunotherapy with anti‐PD1 + anti‐LAG3 was associated with reprogramming of canonically suppressive CD4+ regulatory T cells to an inflammatory state.
Tullia C. Bruno, Anthony R. Cillo
wiley   +1 more source

RETRACTION: "The Proliferation Enhancing Effects of Salidroside on Schwann Cells In Vitro". [PDF]

Evid Based Complement Alternat Med
And Alternative Medicine EC.
europepmc   +1 more source

Alternative filter equipment for ventilation air of separations plants

, 1952
A.G. Blasewitz
openalex   +1 more source

Alternating Hyperphoria [PDF]

British Journal of Ophthalmology, 1954
openaire   +4 more sources

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Isoform switch of T-cell factor7L2 during mouse heart development. [PDF]

J Mol Cell Cardiol Plus
Ye B, Xiao L, Xu Y, Xu H, Li F.
europepmc   +1 more source

Medical alternatives to alternative medicine [PDF]

Cancer, 1999
openaire   +2 more sources

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

Molecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun‐Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng, Young Joo Park, Jong‐Il Kim   +11 more
wiley   +1 more source